MDGL> Nor will I listen to the webcast again. I had to listen to the Q&A a couple of times to catch it all, due to several reasons including what I call slurring of words.
If you ever needed anyone to pitch a program for you, my lead person would be Dr. Friedman. I know in the DuPont Merck buyout by Bristol, he was quite the horse trader on a couple of Ph 3 programs that never crossed the finish line. Bristol was in need of a pipeline, that being before the 'string of pearls' strategy. Alas, the Wallingford BMS site is now history.
Regardless, good management can only take a mediocre molecule so far.
Molecules and management, that is the credo.
